This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, H.
Right arrow Articles by Li, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, H.
Right arrow Articles by Li, J. B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2005, p. 4301-4302, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4301-4302.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Detection of Five Novel CTX-M-Type Extended Spectrum Beta-Lactamases with One to Three CTX-M-14 Point Mutations in Isolates from Hefei, Anhui Province, China


arrow
LETTER
 
Following the introduction of expanded spectrum cephalosporins into clinical usage, the production of extended-spectrum ß-lactamases (ESBLs) by members of the Enterobacteriaceae has been documented (5, 6). One of these ESBLs, CTX-M, has become the predominant ESBL type in eastern Asia, South America, and Eastern Europe. And it also exhibits an overall preferential hydrolysis of cefotaxime and ceftriaxone over ceftazidime and a higher susceptibility to tazobactam than to clavulanate (2, 8, 9). In our study, we also found the dissemination of CTX-M-14 enzyme in our region. Furthermore, several point mutations were also found in the blaCTX-M-14 gene that resulted in amino acid substitution.

A total of 45 strains of Escherichia coli and 53 strains of Klebsiella pneumonia, which were confirmed to be producing ESBLs by inhibitor-potentiated broth dilution testing according to the CLSI (formerly NCCLS)-recommended criterion of 1999 (10), were isolated from patients in four hospitals in Hefei, Anhui province, between 1999 and 2000. Two of the hospitals are tertiary-care teaching hospitals with over 1,000 beds, and the other two are tertiary-care hospitals with more than 500 beds.

PCR and DNA sequencing methods were used in our study. A total of 30 K. pneumonia and 24 E. coli isolates were identified as containing blaCTX-M genes by PCR with newly designed versatile primers for three-group blaCTX-M genes. And then the BLAST program of the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov) was used to search databases for similar nucleotides. The following primers were used in these reactions: for blaCTX-M-1 group genes, primers CTX-M-1A (5'-ACAGCGATAACGTGGCGATG-3') and CTX-M-1B (5'-TCACCCAATGCTTTACCCAG-3'); for blaCTX-M-9 group genes, primers CTX-M-9A (5'-CTGCTTAATCAGCCTGTCGA-3') and CTX-M-9B (5'-TCAGTGCGATCCAGACGAAA-3'); for blaCTX-M-2 group genes, primers TOHO-1A (5'-TGGAAGCCCTGGAGAAAAGT-3') and TOHO-1B (5'-CTTATCGCTCTCGCTCTGTT-3'). All these primer pairs will amplify only part of the ORF of the target gene. Of these, approximately 59.2% (32/54) and 42.6% (23/54) produced CTX-M-9 and CTX-M-1 groups, respectively (one strain was positive for both groups). To derive the whole ORF of the CTX-M-9 group, primers 9-A (5'-CGGAATTCCGGAAGCAGTCTAAATTCTTCGTGAAATAG-3') and 9-B (5'-CGGGATCCCGGGGCCAGTTGGTGATTTGA-3') were used for amplification of a ca. 1,101-bp product containing the whole CTX-M-9 group ORF. Bacterial DNA was prepared by suspension of one or two fresh colonies in 50 µl of sterile distilled water and heating at 95°C for 10 min. PCR amplification was carried out under the following conditions: 94°C for 6 min for predenaturing, followed by 30 cycles of 94°C for 1 min, 60°C for 1 min, and 72°C for 1 min, with a final extension at 72°C for 15 min. All of the nucleotide sequences were determined by bidirectional sequencing of PCR production with an ABI Prism 377-96 automatic DNA sequencer. The results of DNA sequencing with the whole ORF primer indicated that production of the CTX-M-9 group was almost identical to that of CTX-M-14. One to three point mutations occurred in eight isolates, resulting in the amino acid substitutions shown in Table 1. These isolates were designated CTX-M-42, CTX-M-43, CTX-M-44, CTX-M-45, and CTX-M-46.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Point mutation site induced amino acid substitution and relevant data

BlaCTX-M-14 was first submitted to GenBank by A. Chanawong from China in 2000 (AF252622) and was described by L. Ma in 2002. In similarity to CTX-M-9, it was characterized as exhibiting a preference for cefotaxime rather than ceftazidime and had an identical pI (8.0). But only a single amino acid displacement has happened at position 231 (Ala->Val) (4, 7). To our knowledge, amino acid residues Asn104, Asn132, Gly232, Ser237, Asp240, Arg276, and Phe160 are thought to play a role in catalytic properties in the CTX-M enzyme (3, 9). In our study, the replacements of Lys31Asn, Gly46Arg, and Ala51Pro were not at the important positions which relation to hydrolysis as determined on the basis of those previously described, so we think of them as neutrality mutations (1). But further study should be undertaken to interpret why they happened, and more epidemiology experiments need to be performed to reveal the relationship between these strains.


arrow
REFERENCES
 
    1
  1. Blázquez, J., M. C. Negri, M. I. Morosini, J. M. Gómez-Gómez, and F. Baquero. 1998. A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type ß-lactamases. Antimicrob. Agents Chemother. 42:1042-1044.[Abstract/Free Full Text]
    2. 2
  2. Bonnet, R. 2004. Growing group of extended-spectrum ß-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.[Free Full Text]
    3. 3
  3. Bonnet, R., C. Dutour, J. L. M. Sampaio, C. Chanal, D. Sirot, R. Labia, C. De Champs, and J. Sirot. 2001. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240->Gly. J. Clin. Microbiol. 45:2269-2275.
    4. 4
  4. Bou, G., M. Cartelle, M. Tomas, D. Canle, F. Molina, R. Moure, J. M. Eiros, and A. Guerrero. 2002. Identification and broad dissemination of the CTX-M-14 ß-lactamase in different Escherichia coli strains in the northwest area of Spain. J. Clin. Microbiol. 40:4030-4036.[Abstract/Free Full Text]
    5. 5
  5. Bradford, P. A. 2001. Extended-spectrum ß-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.[Abstract/Free Full Text]
    6. 6
  6. Li, J. B., Y. S. Yu, Y. L. Ma, et al. 2001. Prevalence and analysis of risk factors for infections caused by resistant Escherichia coli strains in Anhui, China. Infection 29:228-231.[Medline]
    7. 7
  7. Ma, L., Y. Ishii, F.-Y. Chang, K. Yamaguchi, M. Ho, and L. K. Siu. 2002. CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum ß-lactamase isolated from Escherichia coli. Antimicrob. Agents Chemother. 46:1985-1988.[Abstract/Free Full Text]
    8. 8
  8. Munday, C. J., G. M. Whitehead, N. J. Todd, et al. 2004. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum ß-lactamases in York, UK. J. Antimicrob. Chemother. 54:628-633.[Abstract/Free Full Text]
    9. 9
  9. Munday, C. J., J. Xiong, C. Li, et al. 2004. Dissemination of CTX-M type ß-lactamases in Enterobacteriaceae isolates in the People's Republic of China. Int. J. Antimicrob. Agents 23:175-180.[CrossRef][Medline]
    10. 10
  10. National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial susceptibility testing. 9th informational supplement. NCCLS document M100-S9. National Committee for Clinical Laboratory Standards, Wayne, Pa.
Hui Li
Jia Bin Li*
Department of Infectious Diseases
The First Affiliated Hospital  of Anhui Medical University
218 Ji Xi Rd.
Hefei, Anhui Province, 230022
People's Republic of China

* Phone: (86) 551 2922281, Fax: (86) 551 2922281, E mail: lijiabin948{at}sohu.com

Journal of Clinical Microbiology, August 2005, p. 4301-4302, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4301-4302.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Nagano, Y., Nagano, N., Wachino, J.-i., Ishikawa, K., Arakawa, Y. (2009). Novel Chimeric {beta}-Lactamase CTX-M-64, a Hybrid of CTX-M-15-Like and CTX-M-14 {beta}-Lactamases, Found in a Shigella sonnei Strain Resistant to Various Oxyimino-Cephalosporins, Including Ceftazidime. Antimicrob. Agents Chemother. 53: 69-74 [Abstract] [Full Text]  
  • Jacoby, G. A., Bush, K. (2005). {beta}-Lactamase Nomenclature. J. Clin. Microbiol. 43: 6220-6220 [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, H.
Right arrow Articles by Li, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, H.
Right arrow Articles by Li, J. B.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»